A citation-based method for searching scientific literature

P N Sidharta, A Treiber, J Dingemanse. Clin Pharmacokinet 2015
Times Cited: 26







List of co-cited articles
122 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Tomás Pulido, Igor Adzerikho, Richard N Channick, Marion Delcroix, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Pavel Jansa, Zhi-Cheng Jing, Franck-Olivier Le Brun, Sanjay Mehta,[...]. N Engl J Med 2013
823
65

Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans.
Shirin Bruderer, Gérard Hopfgartner, Michael Seiberling, Janine Wank, Patricia N Sidharta, Alexander Treiber, Jasper Dingemanse. Xenobiotica 2012
58
34

Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist.
Marc Iglarz, Christoph Binkert, Keith Morrison, Walter Fischli, John Gatfield, Alexander Treiber, Thomas Weller, Martin H Bolli, Christoph Boss, Stephan Buchmann,[...]. J Pharmacol Exp Ther 2008
228
26

Macitentan: entry-into-humans study with a new endothelin receptor antagonist.
Patricia N Sidharta, Paul L M van Giersbergen, Atef Halabi, Jasper Dingemanse. Eur J Clin Pharmacol 2011
85
26


Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
John Gatfield, Celia Mueller Grandjean, Thomas Sasse, Martine Clozel, Oliver Nayler. PLoS One 2012
127
23

Inhaled iloprost for severe pulmonary hypertension.
Horst Olschewski, Gerald Simonneau, Nazzareno Galiè, Timothy Higenbottam, Robert Naeije, Lewis J Rubin, Sylvia Nikkho, Rudolf Speich, Marius M Hoeper, Jürgen Behr,[...]. N Engl J Med 2002
23

Sildenafil citrate therapy for pulmonary arterial hypertension.
Nazzareno Galiè, Hossein A Ghofrani, Adam Torbicki, Robyn J Barst, Lewis J Rubin, David Badesch, Thomas Fleming, Tamiza Parpia, Gary Burgess, Angelo Branzi,[...]. N Engl J Med 2005
23


Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment.
Patricia N Sidharta, Nicolas Lindegger, Ivan Ulč, Jasper Dingemanse. J Clin Pharmacol 2014
26
23

Tadalafil therapy for pulmonary arterial hypertension.
Nazzareno Galiè, Bruce H Brundage, Hossein A Ghofrani, Ronald J Oudiz, Gerald Simonneau, Zeenat Safdar, Shelley Shapiro, R James White, Melanie Chan, Anthony Beardsworth,[...]. Circulation 2009
711
19

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
Gerald Simonneau, Robyn J Barst, Nazzareno Galie, Robert Naeije, Stuart Rich, Robert C Bourge, Anne Keogh, Ronald Oudiz, Adaani Frost, Shelmer D Blackburn,[...]. Am J Respir Crit Care Med 2002
965
19

Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension.
Ronald J Oudiz, Nazzareno Galiè, Horst Olschewski, Fernando Torres, Adaani Frost, Hossein A Ghofrani, David B Badesch, Michael D McGoon, Vallerie V McLaughlin, Ellen B Roecker,[...]. J Am Coll Cardiol 2009
166
19

Selexipag for the Treatment of Pulmonary Arterial Hypertension.
Olivier Sitbon, Richard Channick, Kelly M Chin, Aline Frey, Sean Gaine, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Irene M Lang, Ralph Preiss,[...]. N Engl J Med 2015
515
19

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Nazzareno Galiè, Joan A Barberà, Adaani E Frost, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Vallerie V McLaughlin, Andrew J Peacock, Gérald Simonneau, Jean-Luc Vachiery, Ekkehard Grünig,[...]. N Engl J Med 2015
642
19

Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Jasper Dingemanse, Patricia N Sidharta, Willis C Maddrey, Lewis J Rubin, Hani Mickail. Expert Opin Drug Saf 2014
49
19

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
L J Rubin, J Mendoza, M Hood, M McGoon, R Barst, W B Williams, J H Diehl, J Crow, W Long. Ann Intern Med 1990
550
15

Macitentan does not interfere with hepatic bile salt transport.
Alexander Treiber, Päivi Äänismaa, Ruben de Kanter, Stephane Delahaye, Marianne Treher, Patrick Hess, Patricia Sidharta. J Pharmacol Exp Ther 2014
31
15

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension.
Nazzareno Galiè, Alessandra Manes, Luca Negro, Massimiliano Palazzini, Maria Letizia Bacchi-Reggiani, Angelo Branzi. Eur Heart J 2009
455
15

Bosentan therapy for pulmonary arterial hypertension.
Lewis J Rubin, David B Badesch, Robyn J Barst, Nazzareno Galie, Carol M Black, Anne Keogh, Tomas Pulido, Adaani Frost, Sebastien Roux, Isabelle Leconte,[...]. N Engl J Med 2002
15

Updated treatment algorithm of pulmonary arterial hypertension.
Nazzareno Galiè, Paul A Corris, Adaani Frost, Reda E Girgis, John Granton, Zhi Cheng Jing, Walter Klepetko, Michael D McGoon, Vallerie V McLaughlin, Ioana R Preston,[...]. J Am Coll Cardiol 2013
449
15

Lack of Pharmacokinetic Interactions Between Macitentan and a Combined Oral Contraceptive in Healthy Female Subjects.
Noémie Hurst, Matthias Pellek, Jasper Dingemanse, Patricia N Sidharta. J Clin Pharmacol 2016
8
50

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
Nazzareno Galiè, Horst Olschewski, Ronald J Oudiz, Fernando Torres, Adaani Frost, Hossein A Ghofrani, David B Badesch, Michael D McGoon, Vallerie V McLaughlin, Ellen B Roecker,[...]. Circulation 2008
692
15

Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro.
Johanna Weiss, Dirk Theile, Maximilian Alexander Rüppell, Tobias Speck, Adriana Spalwisz, Walter Emil Haefeli. Eur J Pharmacol 2013
38
15

Pharmacokinetics of macitentan in caucasian and Japanese subjects: the influence of ethnicity and sex.
Shirin Bruderer, Joanne Marjason, Patricia N Sidharta, Jasper Dingemanse. Pharmacology 2013
33
15

Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentan.
Oliver Kummer, Manuel Haschke, Felix Hammann, Michael Bodmer, Shirin Bruderer, Yann Regnault, Jasper Dingemanse, Stephan Krähenbühl. Eur J Pharm Sci 2009
34
15

Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions.
Ruben de Kanter, Patricia N Sidharta, Stéphane Delahaye, Carmela Gnerre, Jerome Segrestaa, Stephan Buchmann, Christopher Kohl, Alexander Treiber. Clin Pharmacokinet 2016
17
23

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
K Fattinger, C Funk, M Pantze, C Weber, J Reichen, B Stieger, P J Meier. Clin Pharmacol Ther 2001
366
15

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
R N Channick, G Simonneau, O Sitbon, I M Robbins, A Frost, V F Tapson, D B Badesch, S Roux, M Rainisio, F Bodin,[...]. Lancet 2001
11

Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study.
Ronald J Oudiz, Bruce H Brundage, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Gerald Simonneau, Fady T Botros, Melanie Chan, Anthony Beardsworth, Robyn J Barst. J Am Coll Cardiol 2012
90
11


Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.
M M Hoeper, H Leuchte, M Halank, H Wilkens, F J Meyer, H J Seyfarth, R Wensel, F Ripken, H Bremer, S Kluge,[...]. Eur Respir J 2006
206
11

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Marius M Hoeper, Robyn J Barst, Robert C Bourge, Jeremy Feldman, Adaani E Frost, Nazzareno Galié, Miguel Angel Gómez-Sánchez, Friedrich Grimminger, Ekkehard Grünig, Paul M Hassoun,[...]. Circulation 2013
372
11

PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension.
Nazzareno Galiè, Katharina Müller, Andrea-Viviana Scalise, Ekkehard Grünig. Eur Respir J 2015
118
11

Effect of macitentan on hospitalizations: results from the SERAPHIN trial.
Richard N Channick, Marion Delcroix, Hossein-Ardeschir Ghofrani, Elke Hunsche, Pavel Jansa, Franck-Olivier Le Brun, Sanjay Mehta, Tomás Pulido, Lewis J Rubin, B K S Sastry,[...]. JACC Heart Fail 2015
48
11


Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.
Vallerie V McLaughlin, Ronald J Oudiz, Adaani Frost, Victor F Tapson, Srinivas Murali, Richard N Channick, David B Badesch, Robyn J Barst, Henry H Hsu, Lewis J Rubin. Am J Respir Crit Care Med 2006
424
11


Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.
Vallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, Jean-Christophe Lemarié, Robert Naeije, Milton Packer, Rogério Souza, Victor F Tapson, Jonathan Tolson, Hikmet Al Hiti,[...]. Eur Respir J 2015
144
11

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Raymond L Benza, Dave P Miller, Robyn J Barst, David B Badesch, Adaani E Frost, Michael D McGoon. Chest 2012
654
11

Results of European post-marketing surveillance of bosentan in pulmonary hypertension.
M Humbert, E S Segal, D G Kiely, J Carlsen, B Schwierin, M M Hoeper. Eur Respir J 2007
202
11

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.
N Galiè, Lj Rubin, Mm Hoeper, P Jansa, H Al-Hiti, Gmb Meyer, E Chiossi, A Kusic-Pajic, G Simonneau. Lancet 2008
640
11

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
R J Barst, L J Rubin, W A Long, M D McGoon, S Rich, D B Badesch, B M Groves, V F Tapson, R C Bourge, B H Brundage,[...]. N Engl J Med 1996
11

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
G E D'Alonzo, R J Barst, S M Ayres, E H Bergofsky, B H Brundage, K M Detre, A P Fishman, R M Goldring, B M Groves, J T Kernis. Ann Intern Med 1991
11

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, Henning Tiede, Doerte Huscher, Rudolf Speich, Ekkehard Grünig, Gerd Staehler, Stephan Rosenkranz, Michael Halank,[...]. Circulation 2014
217
11

Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects.
Patricia N Sidharta, Paul L M van Giersbergen, Michael Wolzt, Jasper Dingemanse. Br J Clin Pharmacol 2014
18
16


Pulmonary arterial hypertension: the clinical syndrome.
Yen-Chun Lai, Karin C Potoka, Hunter C Champion, Ana L Mora, Mark T Gladwin. Circ Res 2014
223
11

Endothelin.
Anthony P Davenport, Kelly A Hyndman, Neeraj Dhaun, Christopher Southan, Donald E Kohan, Jennifer S Pollock, David M Pollock, David J Webb, Janet J Maguire. Pharmacol Rev 2016
406
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.